Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China. Maheshwari VK, Slader C, Dani N, Gkitzia C, et al. PLoS One 2021;16:e0259076.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maheshwari VK, Slader C, Dani N, Gkitzia C, et al. Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China. PLoS One 2021;16:e0259076.
PMID: 34695169